nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.279	0.674	CbGbCtD
Esomeprazole—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.135	0.326	CbGbCtD
Esomeprazole—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.029	CcSEcCtD
Esomeprazole—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.0187	CcSEcCtD
Esomeprazole—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0178	CcSEcCtD
Esomeprazole—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0178	CcSEcCtD
Esomeprazole—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0176	CcSEcCtD
Esomeprazole—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.00999	0.017	CcSEcCtD
Esomeprazole—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.00988	0.0168	CcSEcCtD
Esomeprazole—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00956	0.0163	CcSEcCtD
Esomeprazole—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00946	0.0161	CcSEcCtD
Esomeprazole—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.00909	0.0155	CcSEcCtD
Esomeprazole—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00891	0.0152	CcSEcCtD
Esomeprazole—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00835	0.0142	CcSEcCtD
Esomeprazole—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00787	0.0134	CcSEcCtD
Esomeprazole—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00744	0.0127	CcSEcCtD
Esomeprazole—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00668	0.0114	CcSEcCtD
Esomeprazole—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00668	0.0114	CcSEcCtD
Esomeprazole—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00668	0.0114	CcSEcCtD
Esomeprazole—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00659	0.0112	CcSEcCtD
Esomeprazole—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00655	0.0112	CcSEcCtD
Esomeprazole—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00638	0.0109	CcSEcCtD
Esomeprazole—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.0105	CcSEcCtD
Esomeprazole—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00608	0.0104	CcSEcCtD
Esomeprazole—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00608	0.0104	CcSEcCtD
Esomeprazole—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00597	0.0102	CcSEcCtD
Esomeprazole—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.00988	CcSEcCtD
Esomeprazole—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00577	0.00983	CcSEcCtD
Esomeprazole—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00555	0.00946	CcSEcCtD
Esomeprazole—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.00936	CcSEcCtD
Esomeprazole—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.00936	CcSEcCtD
Esomeprazole—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00544	0.00926	CcSEcCtD
Esomeprazole—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.0053	0.00903	CcSEcCtD
Esomeprazole—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00881	CcSEcCtD
Esomeprazole—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.0086	CcSEcCtD
Esomeprazole—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00502	0.00856	CcSEcCtD
Esomeprazole—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00498	0.00848	CcSEcCtD
Esomeprazole—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.0084	CcSEcCtD
Esomeprazole—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00491	0.00836	CcSEcCtD
Esomeprazole—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.00818	CcSEcCtD
Esomeprazole—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.00803	CcSEcCtD
Esomeprazole—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.008	CcSEcCtD
Esomeprazole—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.00796	CcSEcCtD
Esomeprazole—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.00793	CcSEcCtD
Esomeprazole—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.0079	CcSEcCtD
Esomeprazole—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.0078	CcSEcCtD
Esomeprazole—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00454	0.00773	CcSEcCtD
Esomeprazole—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.0077	CcSEcCtD
Esomeprazole—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.00751	CcSEcCtD
Esomeprazole—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00434	0.0074	CcSEcCtD
Esomeprazole—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00413	0.00704	CcSEcCtD
Esomeprazole—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.00689	CcSEcCtD
Esomeprazole—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.00686	CcSEcCtD
Esomeprazole—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00398	0.00679	CcSEcCtD
Esomeprazole—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.00677	CcSEcCtD
Esomeprazole—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0039	0.00665	CcSEcCtD
Esomeprazole—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00389	0.00663	CcSEcCtD
Esomeprazole—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00384	0.00654	CcSEcCtD
Esomeprazole—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00381	0.00649	CcSEcCtD
Esomeprazole—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.00639	CcSEcCtD
Esomeprazole—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.00637	CcSEcCtD
Esomeprazole—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00371	0.00633	CcSEcCtD
Esomeprazole—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00607	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.00604	CcSEcCtD
Esomeprazole—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.006	CcSEcCtD
Esomeprazole—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.00591	CcSEcCtD
Esomeprazole—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.00588	CcSEcCtD
Esomeprazole—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00579	CcSEcCtD
Esomeprazole—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.0034	0.00579	CcSEcCtD
Esomeprazole—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.00577	CcSEcCtD
Esomeprazole—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.00569	CcSEcCtD
Esomeprazole—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.00564	CcSEcCtD
Esomeprazole—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.00564	CcSEcCtD
Esomeprazole—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00563	CcSEcCtD
Esomeprazole—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00563	CcSEcCtD
Esomeprazole—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00552	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00321	0.00548	CcSEcCtD
Esomeprazole—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00321	0.00546	CcSEcCtD
Esomeprazole—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00543	CcSEcCtD
Esomeprazole—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00521	CcSEcCtD
Esomeprazole—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.0052	CcSEcCtD
Esomeprazole—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00517	CcSEcCtD
Esomeprazole—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.00516	CcSEcCtD
Esomeprazole—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.00513	CcSEcCtD
Esomeprazole—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.00511	CcSEcCtD
Esomeprazole—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.0051	CcSEcCtD
Esomeprazole—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.00501	CcSEcCtD
Esomeprazole—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00485	CcSEcCtD
Esomeprazole—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.00482	CcSEcCtD
Esomeprazole—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00469	CcSEcCtD
Esomeprazole—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.00466	CcSEcCtD
Esomeprazole—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.00459	CcSEcCtD
Esomeprazole—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.00455	CcSEcCtD
Esomeprazole—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.00453	CcSEcCtD
Esomeprazole—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00446	CcSEcCtD
Esomeprazole—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00444	CcSEcCtD
Esomeprazole—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00443	CcSEcCtD
Esomeprazole—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.0044	CcSEcCtD
Esomeprazole—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00435	CcSEcCtD
Esomeprazole—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00426	CcSEcCtD
Esomeprazole—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00424	CcSEcCtD
Esomeprazole—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.0042	CcSEcCtD
Esomeprazole—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00418	CcSEcCtD
Esomeprazole—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00416	CcSEcCtD
Esomeprazole—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.00413	CcSEcCtD
Esomeprazole—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.00408	CcSEcCtD
Esomeprazole—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.00407	CcSEcCtD
Esomeprazole—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00405	CcSEcCtD
Esomeprazole—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00395	CcSEcCtD
Esomeprazole—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00391	CcSEcCtD
Esomeprazole—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00385	CcSEcCtD
Esomeprazole—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00385	CcSEcCtD
Esomeprazole—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00385	CcSEcCtD
Esomeprazole—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00384	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00383	CcSEcCtD
Esomeprazole—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00381	CcSEcCtD
Esomeprazole—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00377	CcSEcCtD
Esomeprazole—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00372	CcSEcCtD
Esomeprazole—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00369	CcSEcCtD
Esomeprazole—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00367	CcSEcCtD
Esomeprazole—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00362	CcSEcCtD
Esomeprazole—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00362	CcSEcCtD
Esomeprazole—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00359	CcSEcCtD
Esomeprazole—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00357	CcSEcCtD
Esomeprazole—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00352	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00336	CcSEcCtD
Esomeprazole—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00334	CcSEcCtD
Esomeprazole—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00332	CcSEcCtD
Esomeprazole—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00329	CcSEcCtD
Esomeprazole—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00328	CcSEcCtD
Esomeprazole—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00325	CcSEcCtD
Esomeprazole—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00321	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00319	CcSEcCtD
Esomeprazole—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00318	CcSEcCtD
Esomeprazole—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00316	CcSEcCtD
Esomeprazole—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00316	CcSEcCtD
Esomeprazole—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00304	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00302	CcSEcCtD
Esomeprazole—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00293	CcSEcCtD
Esomeprazole—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00292	CcSEcCtD
Esomeprazole—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00292	CcSEcCtD
Esomeprazole—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00272	CcSEcCtD
Esomeprazole—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00265	CcSEcCtD
Esomeprazole—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00261	CcSEcCtD
Esomeprazole—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00253	CcSEcCtD
Esomeprazole—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00244	CcSEcCtD
Esomeprazole—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00235	CcSEcCtD
Esomeprazole—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00233	CcSEcCtD
Esomeprazole—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00233	CcSEcCtD
Esomeprazole—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00231	CcSEcCtD
Esomeprazole—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00219	CcSEcCtD
